|
BioMed Central (BMC) is a United Kingdom-based, for-profit scientific publisher specialising in open access journal publication. BioMed Central and its sister companies Chemistry Central and PhysMath Central publish over 200 scientific journals. Most BioMed Central journals are now published only online. BioMed Central describes itself as the first and largest open access science publisher. It is owned by Springer Science+Business Media. == History == BioMed Central was founded in 2000 as part of the Current Science Group (now Science Navigation Group, SNG), a nursery of scientific publishing companies. SNG chairman Vitek Tracz developed the concept for the company after NIH director Harold Varmus's PubMed Central concept for open-access publishing was scaled back. The first director of the company was Jan Velterop. In 2002, the company's business model evolved to include article processing charges, and these have since been the primary source of revenue. In October 2008, it was announced that BioMed Central (along with Chemistry Central and PhysMath Central) had been acquired by Springer Science+Business Media, the second largest STM publister. In 2007 Yale University Libraries stopped subsidizing page charges for affiliates of Yale who are using BioMed Central as the publisher of their works. In November 2008, BioMed Central became an official supporting organisation of Healthcare Information For All, a global initiative committed to a future where people are no longer dying for lack of knowledge.〔(【引用サイトリンク】title=HIFA Supporting Organisations )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「BioMed Central」の詳細全文を読む スポンサード リンク
|